An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
Clinical trial NCT02245737 · TERMINATED
Trial details
- NCT number
- NCT02245737
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-30
- Primary completion
- 2018-10-04
- Enrollment
- 2218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.